玻璃体内地塞米松植入术——特发性后巩膜炎的一种新治疗方法：病例报告
Intravitreal dexamethasone implant - a new treatment for idiopathic posterior scleritis: A case report.
作者信息
Zhao Yong-Ji, Zou Yu-Ling, Lu Ying, Tu Meng-Jun, You Zhi-Peng
机构信息
Department of Opthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Department of Ophthalmology, The Eye Hospital, Wenzhou Medical University, Wenzhou 330006, Zhejiang Province, China.
出版信息
World J Clin Cases. 2021 Jan 16;9(2):422-428. doi: 10.12998/wjcc.v9.i2.422.
BACKGROUND
Posterior scleritis is one of the most easily missed and misdiagnosed diseases in ophthalmology. In this case we treated a patient with intravitreal dexamethasone implant that has not been extensively studied before.
CASE SUMMARY
A 40-year-old female patient who had anxiety, palpitation, and insomnia presented with eye pain and decreased vision in the left eye. An eye examination indicated that her visual acuity (VA) was 40/100. Her left eye presented conjunctival edema, mild exophthalmos, clear cornea, KP(-), and clear aqueous humor. In the fundus, there was a cinerous retinal protuberance. Ultrasonography showed "T-sign" and no systemic association was detected in laboratory examination. One month after injection of dexamethasone implant, the patient exhibited VA of 20/20, fundus serous retinal detachment disappeared, and intraocular pressure of both eyes was at the normal level.
CONCLUSION
Intravitreal injection of dexamethasone implant may be a safe and effective treatment for patients with idiopathic posterior scleritis.
背景
后巩膜炎是眼科最易漏诊和误诊的疾病之一。在本病例中，我们治疗了一名此前未被广泛研究的接受玻璃体内地塞米松植入物治疗的患者。
病例摘要
一名40岁女性患者，有焦虑、心悸和失眠症状，出现左眼眼痛和视力下降。眼部检查显示其视力（VA）为40/100。左眼结膜水肿、轻度眼球突出、角膜透明、无角膜后沉着物（KP）、房水清晰。眼底可见灰白色视网膜隆起。超声检查显示“T征”，实验室检查未发现全身相关性。注射地塞米松植入物1个月后，患者视力为20/20，眼底浆液性视网膜脱离消失，双眼眼压处于正常水平。
结论
玻璃体内注射地塞米松植入物可能是特发性后巩膜炎患者的一种安全有效的治疗方法。
Zotero 插件